Deutsche Bank
CSCI

Deutsche Bank’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Deutsche Bank’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-340
Closed -$39K – 4832
2021
Q1 		$39K Buy
+340
New +$37.7K ﹤0.01% 4289
2020
Q4 		– Sell
-25
Closed -$1K – 4538
2020
Q3 		$1K Buy
+25
New +$1.11K ﹤0.01% 4307
2020
Q1 		– Sell
-88
Closed -$8K – 4897
2019
Q4 		$8K Sell
88
-53
-38% -$4.94K ﹤0.01% 4561
2019
Q3 		$14K Sell
141
-817
-85% -$177K ﹤0.01% 4437
2019
Q2 		$282K Sell
958
-195
-17% -$68.7K ﹤0.01% 3639
2019
Q1 		$536K Buy
1,153
+913
+380% +$355K ﹤0.01% 3406
2018
Q4 		$70K Buy
240
+20
+9% +$4.78K ﹤0.01% 4356
2018
Q3 		$38K Buy
220
+3
+1% +$550 ﹤0.01% 4787
2018
Q2 		$42K Sell
217
-16
-7% -$2.95K ﹤0.01% 4837
2018
Q1 		$34K Sell
233
-169
-42% -$33.1K ﹤0.01% 4873
2017
Q4 		$94K Buy
402
+87
+28% +$18.1K ﹤0.01% 4275
2017
Q3 		$64K Sell
315
-78
-20% -$14.4K ﹤0.01% 4304
2017
Q2 		$38K Sell
393
-191
-33% -$30.3K ﹤0.01% 4438
2017
Q1 		$174K Buy
584
+73
+14% +$21.5K ﹤0.01% 3665
2016
Q4 		$183K Sell
511
-212
-29% -$79K ﹤0.01% 3733
2016
Q3 		$248K Buy
723
+83
+13% +$29.1K ﹤0.01% 3547
2016
Q2 		$208K Buy
640
+304
+90% +$109K ﹤0.01% 3755
2016
Q1 		$110K Buy
336
+219
+187% +$72.2K ﹤0.01% 3957
2015
Q4 		$51K Buy
117
+115
+5,750% +$72.2K ﹤0.01% 4392
2015
Q3 		$1K Sell
2
-29
-94% -$42.2K ﹤0.01% 5148
2015
Q2 		$88K Buy
+31
New +$131K ﹤0.01% 4301
2014
Q3 		– Hold
0
– – – 6110
2014
Q2 		– Hold
0
– – – 6095
2014
Q1 		– Sell
-48
Closed -$619K – 5820
2013
Q4 		$668K Buy
48
+38
+380% +$505K ﹤0.01% 2902
2013
Q3 		$145K Buy
10
+4
+67% +$63.6K ﹤0.01% 4273
2013
Q2 		$110K Buy
+6
New +$114K ﹤0.01% 4176

Other funds holding CSCI

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Deutsche Bank's CSCI Position: Q2 2021 in Review

Deutsche Bank sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q2 2021, closing a stake of 340 shares — an estimated $39K sold.

Deutsche Bank first reported a position in CSCI in Q2 2013 and held it in 24 quarters. The position peaked at $668K in Q4 2013. 34 funds tracked by Wall St. Rank hold CSCI as of Q2 2021.

  • Deutsche Bank reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 340 COSCIENS Biopharma Inc. Common Stock shares in Q2 2021, an estimated $39K.
  • Deutsche Bank first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2013 and held it in 24 quarters.
  • Deutsche Bank's COSCIENS Biopharma Inc. Common Stock position peaked at $668K in Q4 2013.
  • 34 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.